nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—DDC—Dopaminergic Neurogenesis—LMX1B—glaucoma	0.048	0.184	CbGpPWpGaD
Cycloserine—SLC36A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A4—glaucoma	0.0404	0.155	CbGpPWpGaD
Cycloserine—Drug hypersensitivity—Travoprost—glaucoma	0.0317	0.0429	CcSEcCtD
Cycloserine—Convulsion—Physostigmine—glaucoma	0.0191	0.0259	CcSEcCtD
Cycloserine—DDC—Dopamine metabolism—SOD1—glaucoma	0.0191	0.0732	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.018	0.0691	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Carteolol—glaucoma	0.0179	0.0242	CcSEcCtD
Cycloserine—Disorientation—Diclofenamide—glaucoma	0.0178	0.0241	CcSEcCtD
Cycloserine—Cardiac failure congestive—Levobunolol—glaucoma	0.0169	0.0229	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—ATOH7—glaucoma	0.0163	0.0623	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.0136	0.052	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.0128	0.0492	CbGpPWpGaD
Cycloserine—Drowsiness—Diclofenamide—glaucoma	0.0123	0.0166	CcSEcCtD
Cycloserine—Coma—Brimonidine—glaucoma	0.0123	0.0166	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.012	0.0461	CbGpPWpGaD
Cycloserine—Drowsiness—Methazolamide—glaucoma	0.0113	0.0153	CcSEcCtD
Cycloserine—Hypersensitivity—Dipivefrin—glaucoma	0.0113	0.0153	CcSEcCtD
Cycloserine—Aggression—Clonidine—glaucoma	0.011	0.0149	CcSEcCtD
Cycloserine—Disorientation—Dorzolamide—glaucoma	0.0104	0.0141	CcSEcCtD
Cycloserine—Cardiac failure congestive—Dorzolamide—glaucoma	0.0103	0.0139	CcSEcCtD
Cycloserine—Osteoarthritis—Brimonidine—glaucoma	0.00976	0.0132	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00917	0.0351	CbGpPWpGaD
Cycloserine—Tremor—Diclofenamide—glaucoma	0.009	0.0122	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00881	0.0337	CbGpPWpGaD
Cycloserine—Vertigo—Methazolamide—glaucoma	0.00795	0.0108	CcSEcCtD
Cycloserine—Confusional state—Diclofenamide—glaucoma	0.00791	0.0107	CcSEcCtD
Cycloserine—Drowsiness—Acetazolamide—glaucoma	0.00784	0.0106	CcSEcCtD
Cycloserine—DDC—Tryptophan metabolism—CYP1B1—glaucoma	0.0078	0.0299	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Clonidine—glaucoma	0.00775	0.0105	CcSEcCtD
Cycloserine—Convulsion—Methazolamide—glaucoma	0.00766	0.0104	CcSEcCtD
Cycloserine—Somnolence—Metipranolol—glaucoma	0.00765	0.0104	CcSEcCtD
Cycloserine—Confusional state—Levobunolol—glaucoma	0.0076	0.0103	CcSEcCtD
Cycloserine—Drowsiness—Brimonidine—glaucoma	0.00752	0.0102	CcSEcCtD
Cycloserine—Confusional state—Methazolamide—glaucoma	0.00728	0.00985	CcSEcCtD
Cycloserine—Paraesthesia—Diclofenamide—glaucoma	0.00704	0.00953	CcSEcCtD
Cycloserine—Somnolence—Diclofenamide—glaucoma	0.00697	0.00943	CcSEcCtD
Cycloserine—Disorientation—Betaxolol—glaucoma	0.00684	0.00926	CcSEcCtD
Cycloserine—Paraesthesia—Levobunolol—glaucoma	0.00677	0.00916	CcSEcCtD
Cycloserine—Paraesthesia—Methazolamide—glaucoma	0.00648	0.00877	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—OPN4—glaucoma	0.00648	0.0248	CbGpPWpGaD
Cycloserine—Feeling abnormal—Diclofenamide—glaucoma	0.00646	0.00874	CcSEcCtD
Cycloserine—Somnolence—Methazolamide—glaucoma	0.00642	0.00868	CcSEcCtD
Cycloserine—Hypersensitivity—Metipranolol—glaucoma	0.00634	0.00858	CcSEcCtD
Cycloserine—Feeling abnormal—Levobunolol—glaucoma	0.00621	0.0084	CcSEcCtD
Cycloserine—Osteoarthritis—Betaxolol—glaucoma	0.00612	0.00829	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00612	0.0234	CbGpPWpGaD
Cycloserine—Psychotic disorder—Betaxolol—glaucoma	0.00598	0.00809	CcSEcCtD
Cycloserine—Vertigo—Bimatoprost—glaucoma	0.00596	0.00807	CcSEcCtD
Cycloserine—Feeling abnormal—Methazolamide—glaucoma	0.00595	0.00805	CcSEcCtD
Cycloserine—Hypersensitivity—Carteolol—glaucoma	0.00588	0.00795	CcSEcCtD
Cycloserine—Disorientation—Timolol—glaucoma	0.00559	0.00757	CcSEcCtD
Cycloserine—Hypersensitivity—Levobunolol—glaucoma	0.00555	0.00751	CcSEcCtD
Cycloserine—Cardiac failure congestive—Timolol—glaucoma	0.00552	0.00746	CcSEcCtD
Cycloserine—Rash—Metipranolol—glaucoma	0.00543	0.00734	CcSEcCtD
Cycloserine—Dermatitis—Metipranolol—glaucoma	0.00542	0.00734	CcSEcCtD
Cycloserine—Drowsiness—Clonidine—glaucoma	0.00542	0.00733	CcSEcCtD
Cycloserine—Headache—Metipranolol—glaucoma	0.00539	0.0073	CcSEcCtD
Cycloserine—Convulsion—Acetazolamide—glaucoma	0.00531	0.00718	CcSEcCtD
Cycloserine—Tremor—Brinzolamide—glaucoma	0.00517	0.007	CcSEcCtD
Cycloserine—Vertigo—Dorzolamide—glaucoma	0.00504	0.00682	CcSEcCtD
Cycloserine—Confusional state—Acetazolamide—glaucoma	0.00504	0.00682	CcSEcCtD
Cycloserine—Vertigo—Travoprost—glaucoma	0.00502	0.00679	CcSEcCtD
Cycloserine—Paraesthesia—Apraclonidine—glaucoma	0.00502	0.00679	CcSEcCtD
Cycloserine—Osteoarthritis—Timolol—glaucoma	0.005	0.00677	CcSEcCtD
Cycloserine—Headache—Carteolol—glaucoma	0.005	0.00676	CcSEcCtD
Cycloserine—Tremor—Pilocarpine—glaucoma	0.00497	0.00672	CcSEcCtD
Cycloserine—Somnolence—Apraclonidine—glaucoma	0.00497	0.00672	CcSEcCtD
Cycloserine—Vertigo—Brinzolamide—glaucoma	0.00496	0.00671	CcSEcCtD
Cycloserine—Rash—Diclofenamide—glaucoma	0.00494	0.00669	CcSEcCtD
Cycloserine—Headache—Diclofenamide—glaucoma	0.00491	0.00665	CcSEcCtD
Cycloserine—Rash—Carbachol—glaucoma	0.00483	0.00653	CcSEcCtD
Cycloserine—Dermatitis—Carbachol—glaucoma	0.00482	0.00652	CcSEcCtD
Cycloserine—Somnolence—Bimatoprost—glaucoma	0.00482	0.00652	CcSEcCtD
Cycloserine—Headache—Carbachol—glaucoma	0.00479	0.00649	CcSEcCtD
Cycloserine—Headache—Levobunolol—glaucoma	0.00472	0.00639	CcSEcCtD
Cycloserine—Confusional state—Dorzolamide—glaucoma	0.00462	0.00625	CcSEcCtD
Cycloserine—Feeling abnormal—Apraclonidine—glaucoma	0.0046	0.00623	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.0046	0.0176	CbGpPWpGaD
Cycloserine—Rash—Methazolamide—glaucoma	0.00455	0.00616	CcSEcCtD
Cycloserine—Dermatitis—Methazolamide—glaucoma	0.00455	0.00615	CcSEcCtD
Cycloserine—Headache—Methazolamide—glaucoma	0.00452	0.00612	CcSEcCtD
Cycloserine—Paraesthesia—Acetazolamide—glaucoma	0.00449	0.00607	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00448	0.0171	CbGpPWpGaD
Cycloserine—Somnolence—Acetazolamide—glaucoma	0.00444	0.00601	CcSEcCtD
Cycloserine—Rash—Latanoprost—glaucoma	0.00441	0.00596	CcSEcCtD
Cycloserine—Dermatitis—Latanoprost—glaucoma	0.0044	0.00596	CcSEcCtD
Cycloserine—Headache—Latanoprost—glaucoma	0.00438	0.00592	CcSEcCtD
Cycloserine—Confusional state—Pilocarpine—glaucoma	0.00436	0.00591	CcSEcCtD
Cycloserine—Paraesthesia—Brimonidine—glaucoma	0.00431	0.00583	CcSEcCtD
Cycloserine—Somnolence—Brimonidine—glaucoma	0.00426	0.00577	CcSEcCtD
Cycloserine—Feeling abnormal—Acetazolamide—glaucoma	0.00412	0.00557	CcSEcCtD
Cycloserine—Hypersensitivity—Apraclonidine—glaucoma	0.00412	0.00557	CcSEcCtD
Cycloserine—Paraesthesia—Dorzolamide—glaucoma	0.00411	0.00557	CcSEcCtD
Cycloserine—Somnolence—Dorzolamide—glaucoma	0.00407	0.00551	CcSEcCtD
Cycloserine—Paraesthesia—Brinzolamide—glaucoma	0.00404	0.00547	CcSEcCtD
Cycloserine—Somnolence—Brinzolamide—glaucoma	0.004	0.00542	CcSEcCtD
Cycloserine—Tremor—Clonidine—glaucoma	0.00397	0.00537	CcSEcCtD
Cycloserine—Paraesthesia—Pilocarpine—glaucoma	0.00389	0.00526	CcSEcCtD
Cycloserine—Somnolence—Pilocarpine—glaucoma	0.00385	0.00521	CcSEcCtD
Cycloserine—Feeling abnormal—Dorzolamide—glaucoma	0.00377	0.00511	CcSEcCtD
Cycloserine—Feeling abnormal—Travoprost—glaucoma	0.00376	0.00509	CcSEcCtD
Cycloserine—Feeling abnormal—Brinzolamide—glaucoma	0.00371	0.00502	CcSEcCtD
Cycloserine—Feeling abnormal—Pilocarpine—glaucoma	0.00357	0.00483	CcSEcCtD
Cycloserine—Hypersensitivity—Brimonidine—glaucoma	0.00353	0.00478	CcSEcCtD
Cycloserine—Dermatitis—Apraclonidine—glaucoma	0.00352	0.00476	CcSEcCtD
Cycloserine—Headache—Apraclonidine—glaucoma	0.0035	0.00474	CcSEcCtD
Cycloserine—Confusional state—Clonidine—glaucoma	0.00349	0.00472	CcSEcCtD
Cycloserine—Tremor—Betaxolol—glaucoma	0.00345	0.00467	CcSEcCtD
Cycloserine—Rash—Bimatoprost—glaucoma	0.00342	0.00462	CcSEcCtD
Cycloserine—Dermatitis—Bimatoprost—glaucoma	0.00341	0.00462	CcSEcCtD
Cycloserine—Headache—Bimatoprost—glaucoma	0.00339	0.00459	CcSEcCtD
Cycloserine—Hypersensitivity—Dorzolamide—glaucoma	0.00337	0.00457	CcSEcCtD
Cycloserine—Hypersensitivity—Travoprost—glaucoma	0.00336	0.00455	CcSEcCtD
Cycloserine—Hypersensitivity—Brinzolamide—glaucoma	0.00332	0.00449	CcSEcCtD
Cycloserine—Vertigo—Betaxolol—glaucoma	0.00331	0.00448	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00329	0.0126	CbGpPWpGaD
Cycloserine—Hypersensitivity—Pilocarpine—glaucoma	0.00319	0.00432	CcSEcCtD
Cycloserine—Headache—Acetazolamide—glaucoma	0.00313	0.00424	CcSEcCtD
Cycloserine—Paraesthesia—Clonidine—glaucoma	0.0031	0.0042	CcSEcCtD
Cycloserine—Somnolence—Clonidine—glaucoma	0.00307	0.00416	CcSEcCtD
Cycloserine—Confusional state—Betaxolol—glaucoma	0.00303	0.00411	CcSEcCtD
Cycloserine—Rash—Brimonidine—glaucoma	0.00302	0.00409	CcSEcCtD
Cycloserine—Dermatitis—Brimonidine—glaucoma	0.00302	0.00409	CcSEcCtD
Cycloserine—Headache—Brimonidine—glaucoma	0.003	0.00407	CcSEcCtD
Cycloserine—Rash—Dorzolamide—glaucoma	0.00289	0.00391	CcSEcCtD
Cycloserine—Dermatitis—Dorzolamide—glaucoma	0.00289	0.0039	CcSEcCtD
Cycloserine—Rash—Travoprost—glaucoma	0.00288	0.00389	CcSEcCtD
Cycloserine—Dermatitis—Travoprost—glaucoma	0.00287	0.00389	CcSEcCtD
Cycloserine—Headache—Dorzolamide—glaucoma	0.00287	0.00388	CcSEcCtD
Cycloserine—Headache—Travoprost—glaucoma	0.00286	0.00387	CcSEcCtD
Cycloserine—Feeling abnormal—Clonidine—glaucoma	0.00285	0.00385	CcSEcCtD
Cycloserine—Rash—Brinzolamide—glaucoma	0.00284	0.00384	CcSEcCtD
Cycloserine—Dermatitis—Brinzolamide—glaucoma	0.00284	0.00384	CcSEcCtD
Cycloserine—Headache—Brinzolamide—glaucoma	0.00282	0.00382	CcSEcCtD
Cycloserine—Rash—Pilocarpine—glaucoma	0.00273	0.00369	CcSEcCtD
Cycloserine—Dermatitis—Pilocarpine—glaucoma	0.00273	0.00369	CcSEcCtD
Cycloserine—Headache—Pilocarpine—glaucoma	0.00271	0.00367	CcSEcCtD
Cycloserine—Vertigo—Timolol—glaucoma	0.00271	0.00366	CcSEcCtD
Cycloserine—Paraesthesia—Betaxolol—glaucoma	0.0027	0.00366	CcSEcCtD
Cycloserine—Hypersensitivity—Clonidine—glaucoma	0.00255	0.00345	CcSEcCtD
Cycloserine—Feeling abnormal—Betaxolol—glaucoma	0.00248	0.00336	CcSEcCtD
Cycloserine—Confusional state—Timolol—glaucoma	0.00248	0.00335	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00246	0.00942	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NARFL—glaucoma	0.00239	0.00915	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CA5A—glaucoma	0.00239	0.00915	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00236	0.00904	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—NGFR—glaucoma	0.00231	0.00884	CbGpPWpGaD
Cycloserine—Hypersensitivity—Betaxolol—glaucoma	0.00222	0.003	CcSEcCtD
Cycloserine—Paraesthesia—Timolol—glaucoma	0.00221	0.00299	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—NTRK1—glaucoma	0.00219	0.0084	CbGpPWpGaD
Cycloserine—Somnolence—Timolol—glaucoma	0.00219	0.00296	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—NGF—glaucoma	0.00218	0.00836	CbGpPWpGaD
Cycloserine—Rash—Clonidine—glaucoma	0.00218	0.00295	CcSEcCtD
Cycloserine—Dermatitis—Clonidine—glaucoma	0.00218	0.00295	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00217	0.00832	CbGpPWpGaD
Cycloserine—Headache—Clonidine—glaucoma	0.00217	0.00293	CcSEcCtD
Cycloserine—Feeling abnormal—Timolol—glaucoma	0.00203	0.00274	CcSEcCtD
Cycloserine—Rash—Betaxolol—glaucoma	0.0019	0.00257	CcSEcCtD
Cycloserine—Dermatitis—Betaxolol—glaucoma	0.0019	0.00257	CcSEcCtD
Cycloserine—Headache—Betaxolol—glaucoma	0.00189	0.00255	CcSEcCtD
Cycloserine—Hypersensitivity—Timolol—glaucoma	0.00181	0.00245	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—FAS—glaucoma	0.00172	0.00658	CbGpPWpGaD
Cycloserine—Rash—Timolol—glaucoma	0.00155	0.0021	CcSEcCtD
Cycloserine—Dermatitis—Timolol—glaucoma	0.00155	0.0021	CcSEcCtD
Cycloserine—Headache—Timolol—glaucoma	0.00154	0.00208	CcSEcCtD
Cycloserine—DDC—Metabolism—CA1—glaucoma	0.00117	0.00447	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CTSA—glaucoma	0.00113	0.00433	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CA2—glaucoma	0.00107	0.00409	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.00104	0.00399	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TNF—glaucoma	0.000893	0.00342	CbGpPWpGaD
Cycloserine—DDC—Metabolism—TXN—glaucoma	0.000752	0.00288	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—TP53—glaucoma	0.000643	0.00246	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTT1—glaucoma	0.000583	0.00223	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCA1—glaucoma	0.000464	0.00178	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP1B1—glaucoma	0.000464	0.00178	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTM1—glaucoma	0.000371	0.00142	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MTHFR—glaucoma	0.000328	0.00126	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOE—glaucoma	0.000305	0.00117	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CAV1—glaucoma	0.000303	0.00116	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NOS3—glaucoma	0.000229	0.000876	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTGS2—glaucoma	0.000209	0.000802	CbGpPWpGaD
